Table 2.
Recurrene Score Results, treatment received and histological response to NAC.
| MULTIDISCIPLINARY TEAM TREATMENT RECOMMENDATION AFTER ONCOTYPE DX TESTING: TOTAL 122 | ||||||
|---|---|---|---|---|---|---|
| PREMENOPAUSAL PATIENTS: n = 45 |
POSTMENOPAUSAL PATIENTS: n = 77 |
|||||
| Recurrence Score <11 n = 8 | Recurrence Score 11–20 n = 14 | Recurrence Score >20 n = 23 | Recurrence Score <11 n = 13 | Recurrence Score 11–25 n = 44 | Recurrence Score >25 n = 20 | |
| No CT | 6 | 9 | 2 | 9 | 24 | 1 |
| Adjuvant CT | 2 | 0 | 0 | 4 | 5 | 0 |
| Neoadjuvant CT | 0 | 5 | 21 | 0 | 15 | 19 |
| RCB TYPE 0-I | N/A | 0/5 0% |
9/21 42.9% |
N/A | 1/15 6.7% |
10/19 52.6% |